ResourceDrug Discovery & Development
Custom synthesis case study of AD 198
25 Feb 2026As biopharmaceutical projects grow increasingly complex, researchers often require highly tailored compounds to support discovery and development. This case study highlights how a customer partnered with CRO, Alfa Chemistry, to obtain a customized batch of AD 198, a novel antitumor PKC‑activating agent, synthesized to meet precise project specifications.
Related Products
Request Quote for All Products
Custom Synthesis
Alfa ChemistryMore than ten years of synthesis experience working with both life sciences and specialty chemicals companies enable Alfa Chemistry to complete any challenging custom synthesis project from milligram to kilogram scale. We will safeguard your confidentiality, as our clients retain all intellectual property of their research.